Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Biocytogen Pharmaceuticals (Beijing) Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 40.67% vs 34.18% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 415.93% vs 108.60% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,495.30",
          "val2": "1,063.00",
          "chgp": "40.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "398.60",
          "val2": "320.30",
          "chgp": "24.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "77.00",
          "val2": "99.40",
          "chgp": "-22.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "71.50",
          "val2": "14.90",
          "chgp": "379.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "187.80",
          "val2": "36.40",
          "chgp": "415.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.20%",
          "val2": "128.80%",
          "chgp": "2.14%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,495.30

1,063.00

40.67%

Operating Profit (PBDIT) excl Other Income

398.60

320.30

24.45%

Interest

77.00

99.40

-22.54%

Exceptional Items

71.50

14.90

379.87%

Consolidate Net Profit

187.80

36.40

415.93%

Operating Profit Margin (Excl OI)

150.20%

128.80%

2.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 40.67% vs 34.18% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 415.93% vs 108.60% in Dec 2024

All Annual Results